Editorial commentary: Atherosclerosis and immunity: A perspective.

[1]  A. Sahebkar,et al.  Atherosclerosis and immunity: A perspective. , 2019, Trends in cardiovascular medicine.

[2]  A. Sahebkar,et al.  Efferocytosis: molecular mechanisms and pathophysiological perspectives , 2018, Immunology and cell biology.

[3]  P. Libby,et al.  Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) , 2018, European heart journal.

[4]  V. Fuster,et al.  Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[5]  R. Baumgartner,et al.  Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice , 2018, Front. Immunol..

[6]  A. Hingorani,et al.  Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study , 2016, Open Heart.

[7]  Inhye Park,et al.  Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development , 2015, Proceedings of the National Academy of Sciences.

[8]  H. Sokol,et al.  Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production. , 2015, Cell metabolism.

[9]  E. Mannarino,et al.  Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis , 2015, European journal of preventive cardiology.

[10]  A. Zernecke.  Dendritic Cells in AtherosclerosisSignificance , 2015 .

[11]  C. Weber,et al.  Neutrophils in atherosclerosis: from mice to man. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[12]  P. Kovanen,et al.  Mast Cells as Effectors in Atherosclerosis , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. Libby,et al.  Inflammation and Immunity in Diseases of the Arterial Tree: Players and Layers , 2015, Circulation research.

[14]  A. Lichtman,et al.  The influence of innate and adaptive immune responses on atherosclerosis. , 2014, Annual review of pathology.

[15]  E. Mannarino,et al.  Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment , 2012, Journal of internal medicine.

[16]  T. Lehtimäki,et al.  Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere Vascular Study , 2010, Annals of medicine.

[17]  M. Pirro,et al.  Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction , 2008, Therapeutic advances in cardiovascular disease.

[18]  E. Mannarino,et al.  Endothelial Injury and Repair: A Novel Theory for Atherosclerosis , 2008, Angiology.

[19]  E. Mannarino,et al.  Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[20]  E. Mannarino,et al.  Effects of fenofibrate on endothelial function and cell adhesion molecules during post‐prandial lipemia in hypertriglyceridemia , 2003, Journal of clinical pharmacy and therapeutics.